Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03865329 · ClinicalTrials.gov registry record · NA

Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations (Pilot Study)

A NA study of COPD Exacerbation, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT03865329 is a NA study of COPD Exacerbation that has completed, run by Mayo Clinic. The registered enrollment target is 9 participants, below the 46-participant average among 3 other COPD Exacerbation trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03865329, a NA study of COPD Exacerbation, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This pilot study will look at investigating barriers, facilitators, adherence and effectiveness of an interactive home-based pulmonary rehabilitation program and health coaching for patients who have recently been hospitalized for a COPD related cause.

Conditions Studied

Interventions

  • BEHAVIORAL Intervention- Home-based Pulmonary Rehabilitation

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2018-01-20
Est. Completion 2019-08-02
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03865329

The ClinicalTrials.gov registry entry for NCT03865329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 46-participant average among 3 other COPD Exacerbation trials with a reported enrollment target (80% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COPD Exacerbation appearing as the primary indexed condition, and to 1 intervention - of which Intervention- Home-based Pulmonary Rehabilitation is the first listed.

NCT03865329 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03865329 about?

NCT03865329 is a clinical study titled "Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations (Pilot Study)". This pilot study will look at investigating barriers, facilitators, adherence and effectiveness of an interactive home-based pulmonary rehabilitation program and health coaching for patients who have recently been hospitalized for a COPD related cause.

What is the current status of trial NCT03865329?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2018-01-20. Estimated completion is 2019-08-02.

What conditions does trial NCT03865329 study?

This clinical trial studies the following conditions: COPD Exacerbation.

What interventions are being tested in trial NCT03865329?

The interventions under investigation include: Intervention- Home-based Pulmonary Rehabilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03865329?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03865329 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD Exacerbation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.